18-33616691-GAA-G
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BS1_SupportingBS2
The NM_030632.3(ASXL3):c.137+9017_137+9018delAA variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00127 in 152,258 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_030632.3 intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00128 AC: 194AN: 152140Hom.: 0 Cov.: 32
GnomAD4 genome AF: 0.00127 AC: 194AN: 152258Hom.: 0 Cov.: 32 AF XY: 0.00134 AC XY: 100AN XY: 74438
ClinVar
Submissions by phenotype
ASXL3-related disorder Uncertain:1
The ASXL3 c.137+9017_137+9018delAA variant is predicted to result in an intronic deletion. In a study of individuals with ASXL3-related syndrome, this variant was not reported in an affected individual, however was noted as loss of function variant (it is not clear which transcript was used) present in gnomAD databalse (Table S7, Schirwani et al 2021. PubMed ID: 34436830). This variant is reported in 0.45% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/18-31196655-GAA-G). . Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at